Cargando…
Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo
We have previously shown that rotavirus (RV) inner capsid protein VP6 has an adjuvant effect on norovirus (NoV) virus-like particle- (VLP-) induced immune responses and studied the adjuvant mechanism in immortalized cell lines used as antigen-presenting cells (APCs). Here, we investigated the uptake...
Autores principales: | Tamminen, Kirsi, Heinimäki, Suvi, Vesikari, Timo, Blazevic, Vesna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204108/ https://www.ncbi.nlm.nih.gov/pubmed/32411793 http://dx.doi.org/10.1155/2020/3194704 |
Ejemplares similares
-
Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles
por: Malm, Maria, et al.
Publicado: (2016) -
Rotavirus VP6 as an Adjuvant for Bivalent Norovirus Vaccine Produced in Nicotiana benthamiana
por: Malm, Maria, et al.
Publicado: (2019) -
Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in Mice
por: Heinimäki, Suvi, et al.
Publicado: (2018) -
Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens Only
por: Heinimäki, Suvi, et al.
Publicado: (2020) -
Expression of influenza A virus-derived peptides on a rotavirus VP6-based delivery platform
por: Gröhn, Stina, et al.
Publicado: (2020)